News Articles 141 - 150 of 160

AHA comment: Poorest people at greater risk of harm from heavy drinking, study finds
News Type: BASL News

Responding to the University of Glasgow study published on Wednesday 10th May 2017 in The Lancet Public Health which found that drinking heavily is more harmful to the poorest people in society, Professor Sir Ian Gilmore, chair of the Alcohol Health Alliance UK (AHA), said:

“The findings in this study are worrying if not altogether surprising. It is clear that the way alcohol is being sold and promoted in Scotland and elsewhere in the UK is harming some of the most vulnerable people in society.

“On the other hand, we know what needs to be done, in particular to tackle the scourge of cheap alcohol. In real terms, alcohol is 60% cheaper than it was in 1980 and measures like strength based pricing would disproportionately benefit the poorest groups, in terms of reduced deaths, illness and hospital admissions. Studies have shown that 82% of the lives saved through minimum unit pricing would come from the lowest income groups.

“Overall, in the first year alone minimum unit pricing in Scotland is expected to save 60 lives and lead to 1,600 fewer hospital admissions and 3,500 fewer crimes, yet its introduction has been held up for years by alcohol industry legal challenges.

“Importantly, minimum unit pricing would leave pub prices untouched, and moderate drinkers would spend only about £2.25 extra per year with a 50p minimum price.”

About the Alcohol Health Alliance UK

The Alcohol Health Alliance UK (AHA) is a group of over 50 organisations including the Royal College of Physicians, Royal College of GPs, British Medical Association, Alcohol Concern and the Institute of Alcohol Studies. The AHA works together to:
- Highlight the rising levels of alcohol-related health harm
- Propose evidence-based solutions to reduce this harm
- Influence decision makers to take positive action to address the damage caused by alcohol misuse

For further information, please contact Matt Chorley, the AHA’s Policy and Communications Officer, at or on 0203 075 1726.

Alcohol-related Hospital Admissions at Record High
News Type: BASL News

New figures released today show that hospital admissions due to alcohol are at their highest ever levels.

The data, summarised in a release from NHS Digital, shows that alcohol-related hospital admissions in England have increased by 64% over the last decade, with an extra 430,000 people being admitted due to alcohol-related causes in 2015/16 compared with 2005/06.

This takes the total number of alcohol-related hospital admissions to over 1.1 million in 2015/16.

Alcohol is linked to over 60 illnesses and diseases, including heart disease, liver disease and cancer. Figures from the local alcohol profiles for England show that admissions due to liver disease have gone up 57% over the last decade, and that the number of people diagnosed with alcohol-related cancer has increased 8%.

In contrast, separate data released today by the Office of National Statistics shows that the proportion of adults drinking is at its lowest level since 2005, with younger people more likely to be abstaining from alcohol. However, 7.8 million people admit to binge drinking on their heaviest drinking day.

In response to the figures, alcohol health experts called for more to be done in the UK to tackle the health harm done by alcohol.

Liver doctor Professor Sir Ian Gilmore, chair of the Alcohol Health Alliance UK (AHA), said:

“These figures show that the UK continues to have a dysfunctional relationship with alcohol."

"We know that over the long term, rates of binge drinking are falling, and more people are choosing to abstain from alcohol."

"Worryingly, however, these trends do not appear big enough to stop alcohol harm from continuing to rise, and the sharp increase in alcohol-related hospital admissions over the last few years means hundreds of thousands more people each year are experiencing the misery associated with harmful alcohol consumption."

"The data released today should be sobering reading for whoever wins the upcoming general election, and we would urge the next government to make tackling alcohol harm an immediate priority to save lives, reduce harm, and reduce the pressure on the NHS.”

The data is available via the following links.
NHS Digital: Statistics on alcohol – England, 2017
Office of National Statistics: Adult drinking habits in Great Britain 2005 to 2016
Local Alcohol Profiles for England

For further information, please contact Matt Chorley, the AHA’s Policy and Communications Officer, at or on 0203 075 1726.

Vacancy for a National HCC-UK Cancer Analyst - closing date 8 May 2017
News Type: BASL News

National HCC-UK Cancer Analyst
Circa £35,000 per annum (London) or £33,000 (Regional).
Full time for 2 years, in the first instance.

We are seeking an experienced cancer analyst to join an exciting new partnership between HCC-UK, the British Association for the Study of the Liver (BASL) and Public Health England (PHE). In this key role, you will be working to improve the outcomes for patients diagnosed with hepatocellular carcinoma (HCC) – the most common type of liver cancer.

You must have demonstrable skills in gathering, understanding, managing, evaluating and manipulating large amounts of data from a range of sources. You will be an excellent communicator, building strong relationships and working collaboratively with key stakeholders in order to obtain vital data.

You will undertake a detailed review of at-risk HCC patients with regard to age, sex, cirrhosis, aetiology of the underlying liver injury (if any); a considered review of treatment effects on survival, adverse events and cost; and an overall examination of the relationship between these and the outcomes.

Based within the National Cancer Registration and Analysis Service (NCRAS) in PHE, you will work closely with a Clinical Research Fellow, representatives from BASL and HCC-UK, and other UK professionals with similar interests. You must be comfortable working in a remote-managed setting.

How to apply:
Please send your CV and a supporting statement together as one document of no more than five pages to Professor Graeme Alexander ( ) or Dr Aileen Marshall ( ). Your supporting statement should explain how you think you meet the requirements of the role and person specification in no more than one side of typed A4. If you require further information, please email Prof Alexander.

Download HCC PHE Cancer Analyst JD Final 210417.pdf

Closing Date: 8th May 2017
First Interview: To be held in May 2017

About the partnership
HCC-UK is a multidisciplinary UK-wide group interested in all facets of management and sits currently under the BASL umbrella. The collaboration between BASL, HCC-UK and PHE proposes to increase our understanding of HCC in England & Wales and to address many of the issues experienced by this patient group. The partnership aims to ensure that liver services in the UK deliver the best available therapy efficiently to all patients with HCC regardless of socioeconomic status or liver centre. The focus will be on extensive use of available retrospective data in the first instance, with prospective data collection a long term intention. The group will also include expertise in health economics for a cost evaluation of HCC, per se, and treatment of this condition in England & Wales.

NICE Final Guidance - Obeticholic acid for treating primary biliary cholangitis
News Type: BASL News

The Final Guidance was published on the NICE website on 26 April 2017.

Click here to read the final guidance.

Foul Play? New report highlights how Alcohol industry bent the rules on advertising during UEFA Euro 2016
News Type: BASL News

A new report highlights how alcohol producers worked to circumvent legislation designed to protect children during the UEFA Euro 2016 football tournament. Researchers at the Institute for Social Marketing, University of Stirling, found over 100 alcohol marketing references per televised match programme in three countries – France, the UK and Ireland. Most marketing appeared in highly visible places, such as pitch-side advertising during the matches. This was the case, despite the fact that the tournament was held in France, where alcohol TV advertising and sports sponsorship is banned under the ‘Loi Évin’.

The report, Foul Play? Alcohol marketing during UEFA Euro 2016, will be launched at the European Healthy Stadia conference at Emirates Stadium on Thursday 27th April.

An analysis of broadcast footage found that alcohol marketing appeared, on average, once every other minute. The majority took the form of ‘alibi’ marketing, whereby indirect brand references are used to promote a product, rather than a conventional logo or brand name. Carlsberg was the most featured brand, accounting for almost all references in each of the three countries, using their slogan ‘Probably the best in the world’ while avoiding the mentioning the product name. ‘Alibi’ marketing was a common practice of tobacco companies in sporting events when advertising restrictions were introduced.

Dr. Richard Purves, Principal Investigator, Institute for Social Marketing, University of Stirling said:

“Beamed to audiences across the world, major sporting events such as the UEFA EURO tournament, present a prime opportunity for alcohol companies to market directly to a global audience. In order to continue to protect children and young people from exposure to alcohol marketing, laws such as those in France need to be upheld and respected by all parties involved and not seen as something to be negotiated.”

Katherine Brown, Director of the Institute of Alcohol Studies said:

“There is strong evidence that exposure to alcohol marketing encourages children to drink earlier and in greater quantities. The findings of this report show that alcohol companies are following in the footsteps of their tobacco colleagues by bending the rules on marketing restrictions putting children’s health at risk.”

Eric Carlin, Director of Scottish Health Action on Alcohol Problems (SHAAP), said:

“Sport should be an alcohol-free space. The presence of alcohol marketing during UEFA EURO 2016 highlights that organisers of sporting events need to hold out against tactics of big alcohol companies to flout legal regulations designed to protect children.”

A copy of the full report is available here: .

The research was carried out by the Institute for Social Marketing, University of Stirling, and funded by the Institute of Alcohol Studies (IAS), Scottish Health Action on Alcohol Problems (SHAAP), and Alcohol Action Ireland.

Interviews available on request in England, Scotland and Ireland. Please contact Habib Kadiri at or 0207 222 4001.

NICE Press Release on testing for blood-borne viruses to people upon entry to prison
News Type: BASL News

NICE has published a press release announcing a draft quality standard which recommends that healthcare staff working in prisons should offer testing for blood-borne viruses like hepatitis B and C, and HIV to people upon entry to prison. It also recommends that they should also assess inmates for their risk of having a sexually transmitted infection (STI).

The press release can be read – here.

NICE addendum publication – Alcohol-use disorders: diagnosis and management of physical complications (CG100)
News Type: BASL News

The final version of the addendum to the Alcohol-use disorders: diagnosis and management of physical complications (CG100) guideline has now been published on the NICE website which can be read > here.

 If you have any queries, please contact .

Bursaries Available - Nonclinical Students to attend BSG 2017 Translational Science Masterclass - 22nd June
News Type: BASL News

Bursaries are available for nonclinical students to attend the BSG 2017 Translational Science Masterclass (Thursday 22 June 2017, Manchester).

A restricted education fund provided by MSD provides ten £50 bursaries to nonclinical scientists who are: 
(1) studying towards a higher degree in a gastroenterology-related area
(2) are not members of the BSG
(3) have registered to attend the Translational Science Masterclass only (Signalling in epithelial cancer and inflammation, Thursday 22 June 2017, Manchester)

Apply to the BSG Education Committee  by Monday 22 May.
The bursaries are available on a first-come, first-served basis.

UK NSC Consultation: Screening for Alcohol Misuse
News Type: BASL News

The UK National Screening Committee (UK NSC) has carried out a national consultation on screening for Alcohol Misuse.

After reviewing comments from stakeholders (including BASL) and the consultation papers the UK NSC have made formal screening recommendations to the four UK countries.

The outcome of the consultation can be found on the UK NSC website here - .

Screening recommendations were made to the following conditions:
 Alcohol misuse
 Asymptomatic bacteriuria
 Fetomaternal alloimmune thrombocytopenia

There is more information about the work and remit of the UK NSC at

ACCEA 2017 Round Open - BASL support has now closed
News Type: BASL News

The Advisory Committee on Clinical Excellence Awards (ACCEA) opened the 2017 awards round on Tuesday 28th February. The final closing date for applications to the ACCEA is 17:00 on Tuesday 25th April 2017.

Application for BASL support
BASL will need to complete the process of selecting applicants who will receive our support shortly. If you would like to apply for BASL support please complete and submit Application Form A to BASL along with any other supplementary CVQs available as detailed below:

Form A – Application Form
Form D – Supplementary CV Questionnaire: Research & Innovation Assessment
Form E – Supplementary CV Questionnaire: Teaching & Training Assessment
Form F – Supplementary CV Questionnaire: Leadership & Management Assessment

In addition BASL also requires a short piece with your application on why you feel you should be supported by BASL.

The deadline for applying for BASL support is 17:00 on Friday 31st March 2017.

All applications have to go through the ACCEA on line system, however downloadable forms to send to BASL can be found on the ACCEA website by clicking > here.

Please be aware that there is a maximum number of supplementary forms that can be completed at each National Level: Bronze and Silver applicants: 1 and Gold applicants: 2. These forms are optional and it is for the applicant to decide whether using them will increase chances of success.

(For use of the Supplementary Forms, please see 'Domains' within the Application form A). Full application guidance can be found on the ACCEA website by clicking > here.

As in previous years BASL would be able to support colleagues directly by nomination for national Gold, Silver and Bronze awards. As a specialist society, BASL cannot make nominations for Platinum awards; this must be done through the applicant’s University/Research Body and Universities UK. BASL can however provide a citation to support an application for a Platinum award.

As a rule, candidates for National Bronze (Level 9) should have a minimum of at least five local Clinical Excellence Awards. Award holders applying for higher level awards or a renewal must specify which achievements have been made after the date of their last award or renewal particularly concentrating on current activities and activities in the last 4 or 5 years, therefore you must date activities.

To apply for BASL support, please follow these steps:
1. Send a completed application form along with a short piece as to why you feel you should be supported to the BASL Secretariat,  by 17:00 on Friday 31st March 2017 for review.
Please understand that in fairness to all applicants, late submissions will not be considered.

2. All applicants will be asked to provide the name of an individual who could write a supporting citation upon submitting their application to BASL. ACCEA regard the citations provided in support of individuals as giving added value to the process. The citation MAY be stronger if it comes from outside ones institution.

3. You must submit your own application to ACCEA online by their deadline 17:00 on Tuesday 25th April. This is your own responsibility.

4. If you are in receipt of BASL support then BASL will upload your citation - please can you ensure your application is uploaded at least one week before the ACCEA deadline - before 17:00 on Tuesday 18th April 2017, so that we have sufficient time to upload your citations onto your application on the ACCEA website.